Short Term Research Training for Medical Students

医学生短期研究培训

基本信息

项目摘要

Abstract The overall goal of this T35 application is to stimulate the development of a new generation of physician-scientists. In order to accomplish this goal, we propose to recruit the best and brightest UTHSC medical students with an interest in medical research and provide a stimulating and structured summer experience between the first and second years of school designed to encourage them to enter into additional research training later in their careers. They will 1) develop written proposals under the supervision of funded, experienced faculty preceptors, 2) conduct their projects in established and productive laboratories or clinical facilities for 2 months between their first year and second years of medical school, 3) report their results in oral and written form, 4) participate in seminars, and 5) receive instruction in the responsible conduct of research. These experiences will enhance their interest in and awareness of careers in academic medicine. Twelve training positions will be offered each year. With the guidance of faculty research mentors, students will develop 4-5 page proposals that are goal-oriented, achievable, and include a hypothesis, literature review, and methodology. Applicants will be selected by peer review based on the quality of the proposal, productivity of the mentor, and training environment. At the end of the project, a final written report is required. Other Program enhancements include a seminar series, special lectures, and opportunities to present and publish the work. Special efforts will continue to be made to attract underrepresented minority participants. Thirty-nine faculty members, holding over $17 million in annual grant awards are proposed as core preceptors. Twenty of the preceptors are engaged in research activities that are funded by NIDDK (13/39) or are directly relevant to NIDDK areas of research interest (7/39). The remainder (19/39) are excellent mentors conducting funded research in areas outside the immediate interest areas of NIDDK. A wide variety of scientific programs (basic, clinical and translational) will be considered for funding in order to accommodate a broad range of medical student interests.
摘要

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Metformin Associated With Increased Survival in Type 2 Diabetes Patients With Pancreatic Cancer and Lymphoma.
  • DOI:
    10.1016/j.amjms.2019.06.002
  • 发表时间:
    2019-07
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Anne Wynn;A. Vacheron;Jeffrey K Zuber;S. Solomon
  • 通讯作者:
    Anne Wynn;A. Vacheron;Jeffrey K Zuber;S. Solomon
Dermatomyositis Developed After Exposure to Epstein-Barr Virus Infection and Antibiotics Use.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAMUEL DAGOGO-JACK, M.D., D.Sc.其他文献

SAMUEL DAGOGO-JACK, M.D., D.Sc.的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAMUEL DAGOGO-JACK, M.D., D.Sc.', 18)}}的其他基金

Ceramides and Sphingolipids as Predictors of Incident Dysglycemia
神经酰胺和鞘脂作为血糖异常事件的预测因子
  • 批准号:
    10361527
  • 财政年份:
    2021
  • 资助金额:
    $ 5.56万
  • 项目类别:
Ceramides and Sphingolipids as Predictors of Incident Dysglycemia
神经酰胺和鞘脂作为血糖异常事件的预测因子
  • 批准号:
    10578762
  • 财政年份:
    2021
  • 资助金额:
    $ 5.56万
  • 项目类别:
Ceramides and Sphingolipids as Predictors of Incident Dysglycemia
神经酰胺和鞘脂作为血糖异常事件的预测因子
  • 批准号:
    10182413
  • 财政年份:
    2021
  • 资助金额:
    $ 5.56万
  • 项目类别:
Short Term Research Training for Medical Students
医学生短期研究培训
  • 批准号:
    9358814
  • 财政年份:
    2017
  • 资助金额:
    $ 5.56万
  • 项目类别:
Pathobiology of Prediabetes in A Bi-Racial Cohort
双种族队列中糖尿病前期的病理学
  • 批准号:
    7213361
  • 财政年份:
    2006
  • 资助金额:
    $ 5.56万
  • 项目类别:
Pathobiology and Reversibility of Prediabetes in a Biracial Cohort
混血儿群体中糖尿病前期的病理学和可逆性
  • 批准号:
    8734383
  • 财政年份:
    2006
  • 资助金额:
    $ 5.56万
  • 项目类别:
Pathobiology and Reversibility of Prediabetes in a Biracial Cohort
混血儿群体中糖尿病前期的病理学和可逆性
  • 批准号:
    8580480
  • 财政年份:
    2006
  • 资助金额:
    $ 5.56万
  • 项目类别:
Pathobiology of Prediabetes in A Bi-Racial Cohort
双种族队列中糖尿病前期的病理学
  • 批准号:
    7408584
  • 财政年份:
    2006
  • 资助金额:
    $ 5.56万
  • 项目类别:
Pathobiology of Prediabetes in A Bi-Racial Cohort
双种族队列中糖尿病前期的病理学
  • 批准号:
    7588751
  • 财政年份:
    2006
  • 资助金额:
    $ 5.56万
  • 项目类别:
Pathobiology of Prediabetes in A Bi-Racial Cohort
双种族队列中糖尿病前期的病理学
  • 批准号:
    7081734
  • 财政年份:
    2006
  • 资助金额:
    $ 5.56万
  • 项目类别:

相似海外基金

Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
Einstein-Montefiore Clinical and Translational Science Award Hub
爱因斯坦-蒙蒂菲奥里临床和转化科学奖中心
  • 批准号:
    10622099
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
University of Kansas Cancer Center Paul Calabresi K12 Career Development Award for Clinical Oncology
堪萨斯大学癌症中心 Paul Calabresi K12 临床肿瘤学职业发展奖
  • 批准号:
    10647369
  • 财政年份:
    2023
  • 资助金额:
    $ 5.56万
  • 项目类别:
Institutional Clinical and Translational Sciences Award
机构临床和转化科学奖
  • 批准号:
    10487653
  • 财政年份:
    2022
  • 资助金额:
    $ 5.56万
  • 项目类别:
Clinical and Translational Science Award
临床和转化科学奖
  • 批准号:
    10674531
  • 财政年份:
    2022
  • 资助金额:
    $ 5.56万
  • 项目类别:
The Tisch Cancer Institute (TCI) Paul Calabresi K12 Career Development Award for Clinical Oncology
蒂施癌症研究所 (TCI) Paul Calabresi K12 临床肿瘤学职业发展奖
  • 批准号:
    10434380
  • 财政年份:
    2022
  • 资助金额:
    $ 5.56万
  • 项目类别:
The Tisch Cancer Institute (TCI) Paul Calabresi K12 Career Development Award for Clinical Oncology
蒂施癌症研究所 (TCI) Paul Calabresi K12 临床肿瘤学职业发展奖
  • 批准号:
    10623252
  • 财政年份:
    2022
  • 资助金额:
    $ 5.56万
  • 项目类别:
Clinical and Translational Science Award
临床和转化科学奖
  • 批准号:
    10656986
  • 财政年份:
    2022
  • 资助金额:
    $ 5.56万
  • 项目类别:
Research Program Award (R35 Clinical Trial Optional) - Dr. Robyn Klein NINDS
研究计划奖(R35 临床试验可选)- Robyn Klein NINDS 博士
  • 批准号:
    10397683
  • 财政年份:
    2021
  • 资助金额:
    $ 5.56万
  • 项目类别:
Research Program Award (R35 Clinical Trial Optional) - Dr. Robyn Klein NINDS
研究计划奖(R35 临床试验可选)- Robyn Klein NINDS 博士
  • 批准号:
    10239672
  • 财政年份:
    2021
  • 资助金额:
    $ 5.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了